The Union Health Ministry has clarified that there has been no change in the treatment plan for Tuberculosis treatment in India, countering misleading claims circulating on social media. Recent online posts suggested that the country had adopt...
Indian Immunologicals Limited has reported its highest-ever annual revenue of ?1,586 crore for the financial year 2025–26, marking a major milestone in the company’s growth. The strong performance reflects increasing demand for vaccine manufactu...
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) to market Fingolimod Capsules 0.5 mg in the United States. The approval marks another important step in the company’s efforts to strength...
India’s Sun Pharmaceutical Industries has announced a major Sun Pharma Organon acquisition, agreeing to buy U.S.-based Organon & Co. in an all-cash deal valued at USD 11.75 billion, including debt. The company will pay USD 14 per share to acquire...
Malaria’s impact on growth continues to be a critical concern for healthcare systems and emerging economies, particularly in regions where the disease remains endemic. The reality of slow progress becomes evident when evaluating how malaria...
In a move to strengthen workforce readiness, the Pharmaceutical Academy for Global Excellence (PAGE) has partnered with 8chili Inc. to roll out an AI and VR pharma manufacturing training platform in India. The initiative targets a critical skills...
A counterfeit medicine operation involving fake versions of Mounjaro has come under investigation in India after packaging errors exposed suspicious products circulating in the market. Authorities say the discovery highlights growing concern...
Gujarat Themis Biosyn Limited (GTBL) has announced a major step in its global expansion with the signing of an agreement to acquire a portfolio of anti-tuberculosis and anti-infective brands from Sanofi. The GTBL acquisition of Sanofi TB...
The Merck & Google Cloud partnership is set to reshape how one of the world’s largest pharmaceutical companies operates, with a deal worth up to USD 1 billion aimed at turning Merck into a fully AI-enabled enterprise.
Biocon denosumab biosimilars have secured a major regulatory win, with Health Canada granting a Notice of Compliance (NOC) for two of the company’s products—Bosaya and Vevzuo—on April 3, 2026. The approval marks a significant step as Biocon...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")